The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO)
Recruiting now
Conditions studied: Alzheimer s Disease
In brief
The goal of this study is to show a significant difference in performance between 2 groups of participants (healthy elderly people vs. people with Alzheimer Disease) in an identification and naming task involving famous monuments.
Key facts
- Study ID
- NCT07367880
- Run by
- University Hospital, Grenoble
- People needed
- 220
- Starts
- 2026-02-23
- Expected to finish
- 2032-02-01
- Last updated by the study team
- 2026-05-26
Who can join
Age: 50 and older, up to 95. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Alzheimer's disease:
- Age ≥ 50 years and older
- Possible or probable diagnosis of Alzheimer's disease according to the revised criteria of Mac Khann et al., 2011.
- Score 18≤ MMSE ≤26
- Controls:
- Age ≥ 50 years and older
- MMSE score ≥ 26 For all subjects
- No objection from the participant
You may not qualify if…
- Alzheimer's disease:
- Persons referred to in Articles L1121-5 to L1121-8 of the CSP
- Controls:
- Memory complaints
- Persons referred to in Articles L1121-5 to L1121-8 of the CSP For all subjects
- Significant neurological or psychiatric history
- Taking psychotropic medication (neuroleptics)
- Poor command of the French language, comprehension difficulties
- Significant hearing or visual impairments (diplopia, nystagmus, scotoma, etc.)
- Insufficient exposure to the media and/or socio-cultural knowledge (questionnaire) ; Deficit in face recognition (Benton Face Recognition Test)
Where it is running
- CHU Grenoble Alpes — Grenoble, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.